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INTRODUCTION 
Magnesium is one of the four most common electrolytes 
in the human body, which is an essential co-factor in 
more than 300 enzymatic reactions. Magnesium plays a 
crucial role in the synthesis of compounds involving 
energy-rich bonds as well as their utilization either by 
transfer or hydrolysis of the energy-rich bond [1]. 
Magnesium plays a vital role in cellular energy 
metabolism, cell replication, and protein synthesis [2].  
It is involved in many vital processes, such as cardiac 
excitability [3], transmembrane ion flux, and 
neurotransmitter release and gating of calcium ion 
channels[4]. In many respects, magnesium serves as a 
physiological antagonist to calcium [5]. The relationship 
between calcium and magnesium provides information 
regarding the importance of magnesium in critical care 
medicine [2]. Various studies have reported low serum 
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and myocardial magnesium and abnormal magnesium 
tolerance tests in patients with acute myocardial 
infarction [6-10]. Magnesium therapy has been 
advocated [11] but the Fourth International Study of 
Infarct  Survival (ISIS-4) mega-study failed to confirm 
the utility of magnesium therapy [12]. 
Magnesium deficiency is common among hospitalized 
patients (7-11%), and it has been found in 20-60% of 
intensive care unit (ICU) admitted patients [13]. In 
nearly half of various electrolyte abnormalities, 
hypomagnesaemia is found to be a comorbid condition 
[14], which indicates its essential role in ICU patients 
[2]. Large number of workers have reported regarding 
the association of several drugs with urinary magnesium 
wasting [15]. In many instances, the mechanism of 
action of drugs such as antimicrobial agents, 
chemotherapeutic agents, diuretics, beta-adrenergic 
agonists, and others is unclear [16].  
Though magnesium deficiency is common in the 
various populations, many patients with magnesium 
deficiency and hypomagnesaemia remain 
asymptomatic. Signs and symptoms of magnesium 
deficiency are usually not seen until serum magnesium 
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decreases to 0.5 mmol/L or lower. In a study from 
Mumbai, India, it was reported that hypomagnesaemia 
was associated with a high mortality rate in critically ill 
patients with high prevalence, and with a high rate of 
ventilator support [17]. 
In many clinical situations, the actual relevance of 
hypomagnesaemia can be challenging to evaluate; this 
is mainly in the frail elderly [18]. 
In our previous study, we have observed high 
prevalence (17%) of hypomagnesaemia in healthy 
subjects [19], consuming different types of drinking 
water, including filtered and non-filtered water sources. 
Patients admitted to ICCU units are mostly critically ill 
with severe cardiac diseases. The present study was 
taken up by looking into the role of magnesium in 
cardiac diseases and prevalence of its acute deficiency 
particularly in the patients with critical illness and 
avenues available to maintain adequate levels of this 
element. Another pertinent point while carrying out this 
study was whether serum magnesium itself 
independently associated or only a marker or 
representative of comorbidity in critically ill patients 
admitted to ICCU units. 
MATERIAL AND METHODOLOGY    
Study design: An observational analytical study  
Ethical approval: Institutional ethical committee 
approval was duly obtained. Inform consent was 
obtained from the participants. 
Study location: Present study was carried out in the 
Biochemistry Department, SMIMER 
Study duration: One year.  
Sample size: The present study was carried out for the 
period of one year during which total 557 subjects were 
included in the study; comprising 185 healthy subjects, 
93 subjects admitted to ICCU unit, and 279 subjects 
admitted to general ward (non-ICCU). 
Inclusion criteria: Patients admitted to the ICCU unit, 
and general ward of Medicine department were selected 
for the study. Both ICCU and non-ICCU subjects were 
admitted for either or both diabetes and cardiovascular 
diseases. Based on acute clinical symptoms, patients 
were diagnosed for cardiovascular diseases and were 
admitted.  
Exclusion criteria: Patients with other conditions such 
as kidney, liver, brain, and other critical illnesses and 
suffering from infective diseases were excluded from 
the study. 
Methodology 
On hospitalization, detailed information of these 
patients regarding demographic data, diet, dietary 
habits, family history, past, and present clinical history 
was obtained as part of clinical procedures. Either on 
the same day or next day after hospitalization, fasting 
blood samples were collected in the morning for 
magnesium and other biochemical investigations. 
Healthy subjects were selected randomly from hospital, 
and college staff, and from society. Healthy subjects 
were without any present or past history of disorders. 
After 15 hours of overnight fast after the last dinner, 
blood samples were collected by standard procedures 
for biochemical investigations: magnesium, cardiac 
profile, and renal profile. All biochemical investigations 
were estimated by using standardized methods (20-30) 
on ERBA XL autoanalyzer, Transasia Biomedical Pvt. 
Ltd. Mumbai within 4 to 6 hours of collection of 
samples. Internal and external quality checks were 
strictly followed for these investigations, and statistical 
data was well within required levels for SD and CV  
(Coefficient of variance). 
Statistical analysis: Results are expressed as Mean and 
SD, and appropriate statistical tools are used, such as t 
test and correlations to arrive at conclusions. 
 
RESULTS  
A total of 557 subjects were assessed for magnesium 
status in three groups: 93 ICCU hospitalized patients, 
279 were Non-ICCU hospitalized patients, and 185 
were healthy subjects. Table 1 shows the distribution of 
these subjects as per their lifestyle, diet type, and type of 
water usage for drinking. Among healthy subjects, 32% 
and 68% of subjects were using filtered and non-filtered 
water respectively. Whereas among ICCU and non-
ICCU subjects, 11 and 12% were filtered water users, 
and 89 and 88% were non-filtered water users. Both in 
healthy controls and hospitalized patients (ICCU and 
non ICCU), the number of urban subjects (>82%) were 
much more than rural subjects (<18%). 
Table 2 presents the data regarding the levels of serum 
calcium and magnesium in all three groups. 
Hypomagnesaemia of 18%, 42%, and 36% was 
observed in healthy subjects, ICCU hospitalized 
patients, and Non-ICCU hospitalized patients, 
respectively. 
As compared to healthy subjects, almost all biochemical 
parameters were found to be significantly altered in 
ICCU patients with significant hypomagnesaemia (p-
value < 0.05) (Table 3). A significant difference (p = 
0.00) in the serum magnesium levels was observed in 
hospitalized patients of both ICCU (1.68 ± 0.55) and 
non-ICCU (1.73 ± 0.53) separately and also in both 
together (1.72 ± 0.53) compared to healthy subjects 
(1.93 ± 0.46). Similarly, serum calcium, HDL 
cholesterol levels were significantly lower among 
hospitalized subjects in both ICCU and non-ICCU 
compared to healthy subjects. Whereas plasma glucose, 
serum creatinine, cholesterol, triglycerides, CPK, and 
CK-MB levels were significantly higher among ICCU 
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and non-ICCU hospitalized subjects compared to 
healthy subjects. 
Table 4 presents the comparison of other biochemical 
parameters, including magnesium between filtered 
water users and non-filtered water users in healthy 
subjects. No significant difference in serum calcium and 
other biochemical parameters was observed between 
filtered and nonfiltered water users.  Table 5 shows the 
comparison of biochemical parameters, including 
magnesium between filtered water users and non-
filtered water users in   ICCU subjects. No significant 
difference was observed between filtered and 
nonfiltered water users.   
Table 6 shows the comparison of biochemical 
parameters, including magnesium between filtered 
water users and non-filtered water users in Non-ICCU 
hospitalized patients. Similar to healthy and ICCU 
subjects in non-ICCU subjects also no significant 
difference was observed in various biochemical 
parameters between filtered and nonfiltered water users.  
One common observation was that, in all these groups, 
serum magnesium levels were significantly low among 
filtered water users as compared to non-filtered water 
users (p-value < 0.05). Serum calcium ranged from 6.2 
to 14.0 mg/dl, 6.0 to 11.80 mg/dl and 6.50 to 12.50 mg 
dl in healthy subjects, ICCU subjects, and non-ICCU 
subjects, respectively. Whereas serum magnesium 
ranged from 0.46 to 3.00 mg/dl, 0.20 to3.00 mg/dl, and 
0.20 to 3.60 mg/dl in healthy, ICCU and non-ICCU 
subjects respectively. Among all these groups, no 
significant difference was found between lipid and renal 
profile markers between filtered and non-filtered water 
users.  
Table 7 shows the incidence of hypomagnesaemia 
among filtered and non-filtered water users in study 
groups: healthy subjects, ICCU, and non-ICCU 
subjects. Incidence of hypomagnesaemia was 
predominantly and significantly (p = 0.040, p = 0.001) 
high among filtered water users across the groups and 
ranged from 27% in healthy subjects to almost 90% in 
ICCU patients, on the other hand, the incidence of 
normomagnesemia was prevalent among non-filtered 
water users.   
 
DISCUSSION 
Magnesium is an alkaline metal, available to humans by 
two major sources, water, and food. Magnesium is 
mainly intracellular with almost half of the stored 
magnesium is found in muscles and soft tissues. It is 
Description Healthy Subjects n (%) ICCU patients   n (%) NON-ICCU patients n (%) 
Subjects (n) 185 93 279 
Males 94 (51%) 58 (62%) 133 48%) 
Females 91 (49%) 35 (38%) 146 (52%) 
Vegetarians 113 (61%) 53 (57%) 161 (58%) 
Non-vegetarians 72 (39%) 40 (43%) 118 (42%) 
Smoking 29 (16%) 41 (44%) 82 (29%) 
Alcohol 23 (12%) 17 (18%) 43 (15%) 
Filtered water users 60 (32%) 10 (11%) 35 (12%) 
Non-filtered water users 125 (68%) 83 (89%) 244 (88%) 
Rural 33 (18%) 5 (5%) 20 (7%) 
Urban 152 (82%) 88 (95%) 259 (93%) 
Age (Years) 38 ± 17 54 ± 16 51 ± 13 
BMI (kg/m2)  23.57 ± 4.68 25.82 ± 4.35 25.61 ± 4.80 
Table 1. Demographic data of study groups 
Description 
Healthy Sub-
jects (185) 
ICCU  
patients (93) 
NON-ICCU 
(279) 
All ICCU + Non-ICCU 
(372) 
Calcium (mg/dl) 9.45 ± 1.18 8.73± 1.01 8.92 ± 0.92 8.77 ± 0.94 
Magnesium (mg/dl) 1.93 ± 0.46 1.68 ± 0.55 1.73 ± 0.53 1.72 ± 0.53 
Hypomagnesaemia n (%) 33 (18%) 39 (42%) 101 (36.1%) (139)37.4% 
Table 2. Magnesium, calcium status in healthy subjects, ICCU and Non-ICCU patients  
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mainly excreted through urine with the minor amount 
by sweat and intestinal secretion. Magnesium is the 
most precious element in view of cardiac health. 
Various clinical studies reported regarding the 
prevalence of hypomagnesaemia in hospitalized 
patients, including those admitted in intensive care 
units. Prevalence varied from 7 to 52% as per various 
reports [20-24]. Whereas some workers reported an 
incidence of hypomagnesaemia in hospitalized patients 
up to 12% and as higher as up to 60% in patients in the 
intensive care unit [23, 25]. Nornoha and Matuscheake 
(2002) observed variation in the incidence of 
hypomagnesaemia from 20 to 65% in hospitalized 
Description 
A B 
p value  
(A&B) 
C 
p value 
 (A & C) 
Healthy Sub-
jects  (185) 
ICCU patients     
(93) 
ICCU+Non-ICCU 
FBS (mg/dl) 89.50 ± 18.56 130.45 ± 88.98 0.00 143.22 ± 88.04 0.00 
RBS (mg/dl) 94.48 ± 19.49 166.44 ± 102.12 0.00 163.30 ± 95.11 0.00 
Creatinine (mg/dl) 0.76 ± 0.18 1.18 ± 0.72 0.00 0.93 ± 0.54 0.00 
Cholesterol Total (mg/dl) 171.26 ± 35.23 152.41 ± 47.54 0.00 169.73 ± 44.94 0.75 
Triglycerides (mg/dl) 126.11 ± 66.77 139.02 ± 69.73 0.14 148.84 ± 68.80 0.00 
HDL Cholesterol (mg/dl) 44.48 ± 11.55 33.82 ± 10.87 0.00 37.23 ± 10.53 0.00 
LDL Cholesterol (mg/dl) 101.36 ± 30.03 91.38 ± 41.76 0.02 102.72 ± 40.90 0.74 
Protein Total (g/dl) 7.41 ± 0.64 6.46 ± 0.85 0.00 7.13 ± 0.84 0.00 
Albumin (g/dl) 4.54 ± 0.60 3.75 ± 0.57 0.00 4.10 ± 0.56 0.00 
CPK Total (U/L) 101.76 ± 46.26 226.86 ± 436.22 0.00 131.88 ± 234.44 0.95 
CK-MB (U/L) 34.25 ± 19.69 81.46 ± 158.86 0.05 89.25 ± 266.12 0.47 
Calcium (mg/dl) 9.45 ± 1.14 8.73 ± 1.01 0.00 8.87 ± 0.94 0.00 
Magnesium (mg/dl) 1.93 ± 0.46 1.68 ± 0.55 0.00 1.72 ± 0.53 0.00 
Systolic P (mmhg) 124.45 ± 7.80 129.29 ± 22.92 0.01 128 ± 16 0.08 
Diastolic P (mmhg) 81.38 ± 5.43 83.89 ± 9.44 0.01 83 ± 8 0.05 
BMI (kg/m2) 23.53 ± 4.69 25.82 ± 4.35 0.00 25.66 ± 4.69 0.00 
Table 3. Laboratory values of biochemical parameters in ICCU patients 
Table 4. Biochemical parameters in filtered and non-filtered water users among healthy subjects  
Parameter Filtered water users Non-filtered water users p-value 
Number 60 125   
RBS (mg/dl) 89.63 ± 13.49 95.35 ± 22.75 0.07 
Creatinine (mg/dl) 0.75 ± 0.22 0.77 ± 0.17 0.49 
Cholesterol Total (mg/dl) 172.48 ± 38.87 170.68 ± 33.49 0.74 
Triglycerides (mg/dl) 121.96 ± 62.79 128.10 ± 68.75 0.56 
HDL Cholesterol (mg/dl) 45.14 ± 11.19 44.16 ± 11.75 0.59 
LDL Cholesterol (mg/dl) 102.80 ± 33.59 100.66 ± 28.29 0.87 
Calcium (mg/dl) 9.45 ± 1.18 9.45 ± 1.12 1.0 
Magnesium (mg/dl) 1.77 ± 0.36 2.01 ± 0.48 < 0.01 
Systolic P (mmhg) 125.20 ± 7.21 122.90 ± 8.77 0.08 
Diastolic P (mmhg) 81.79 ± 4.60 80.53 ± 6.82 0.19 
BMI (kg/m2) 23.85 ± 4.78 22.98 ± 4.45 0.22 
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critically ill patients [2]. Rubeiz et al. (1983) reported 
that hypomagnesaemia in intensive care patients was 
associated with increased mortality [26]. The present 
study comprised of 557 individuals, of which 185 were 
healthy controls devoid of any disorders and 93 patients 
afflicted with various types disorders (diabetes and 
cardiovascular diseases) admitted to ICCU unit and 279 
non-ICCU but hospitalized patients. 
In ICCU patients, there were 39 subjects who had 
hypomagnesaemia (42%) with serum magnesium level 
of 1.16 ± 0.37 mg/dl compared to the level of 2.05 ± 
0.31mg/dl in the normomagnesaemic subjects. 
Prevalence of hypomagnesaemia was higher than the 
prevalence reported by some workers [2, 25, 27] 
Limaye et al. [17] observed hypomagnesaemia in 51% 
of patients admitted to MICU in the tertiary care 
hospital in the city of Mumbai. In the present study, an 
Table 5. Biochemical parameters in filtered and non-filtered water users among ICCU patients 
Parameter Filtered water users Non-filtered water users p-value 
Number 10 83   
RBS (mg/dl) 146.30 ± 31.62 168.88 ± 107.40 0.15 
Creatinine (mg/dl) 0.99 ± 0.28 1.21 ± 0.75 0.09 
Cholesterol Total (mg/dl) 145.00 ± 45.71 153.30 ± 47.95 0.60 
Triglycerides (mg/dl) 138.06 ± 76.57 139.14 ± 69.37 0.97 
HDL Cholesterol (mg/dl) 34.41 ± 13.64 33.75 ± 10.59 0.89 
LDL Cholesterol (mg/dl) 82.94 ± 33.36 92.39 ± 42.72 0.43 
CPK Total (U/L) 178.40 ± 95.46 232.70 ± 460.62 0.36 
Calcium (mg/dl) 8.66 ± 0.89 8.74 ± 1.02 0.81 
Magnesium (mg/dl) 1.35 ± 0.44 1.72 ± 0.55 <0.05 
Systolic P (mmhg) 139.40 ± 25.25 128.07 ± 22.49 0.20 
Diastolic P (mmhg) 86.20 ± 12.45 83.61 ± 9.07 0.54 
BMI (kg/m2) 25.70 ± 3.88 25.83 ± 4.42 0.92 
Table 6. Biochemical parameters in filtered and non-filtered water users among NON-ICCU patients 
Parameter Filtered water users Non-filtered water users p-value 
Number 36 243   
RBS (mg/dl) 146.30 ± 31.62 168.88 ± 107.40 0.15 
Creatinine (mg/dl) 0.77± 0.22 0.86± 0.46 0.25 
Cholesterol Total (mg/dl) 184.25± 35.19 174.21± 43.49 0.19 
Triglycerides (mg/dl) 158.81± 72.20 151.13± 67.81 0.53 
HDL Cholesterol (mg/dl) 40.68± 12.17 38.03± 09.84 0.14 
LDL Cholesterol (mg/dl) 113.53± 30.78 105.46± 41.10 0.26 
CPK Total (U/L) 97.36± 41.74 100.65± 83.91 0.82 
Calcium (mg/dl) 8.84± 0.87 8.94± 0.93 0.58 
Magnesium (mg/dl) 1.51 ± 0.59 1.77 ± 0.51 <0.05 
Systolic P (mmhg) 131.17± 15.20 127.67 ± 13.03 0.14 
Diastolic P (mmhg) 84.39± 11.36 83.13± 6.18 0.32 
BMI (kg/m2) 26.37± 3.95 25.50± 4.91 0.31 
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incidence of 42% of hypomagnesaemia was observed, 
though slightly lower than that of reported value by 
Limaye et al. [17] from Mumbai but comparable to the 
studies reported from elsewhere. On follow up of 
discharged patients, we have found that six patients 
out of 93 from ICCU unit expired within a month after 
discharge from ICCU unit. Thus, a mortality rate of 
6.5% was recorded. 
Hypomagnesaemia in ICU patients was reported to be 
associated with an increased rate of mortality [26]. A 
two-fold increase in the mortality rate was reported in 
ICU patients with hypomagnesaemia compared to 
normomagnesaemia. Chernow et al [25] observed 41% 
mortality in hypomagnesaemic subjects compared to 
only 13% of mortality rate in normomagnesaemics 
subjects. Rubeiz et al [26] reported 46% mortality rate 
in hypomagnesaemic subjects whereas this rate was 
25% in normomagnesaemic subjects. Safavi et al 
(2007) [28]  found 55% incidence of mortality in 
hypomagnesaemic subjects and 35% in 
normomagnesaemic subjects. Limaye et al [17] had 
observed 51% of mortality rate in hypomagnesaemic 
subjects compared to 31% in normomagnesaemic 
subjects. Guerin et al [29] had found no difference in 
the mortality rate between the hypomagnesaemic and 
normomagnesaemic subjects who were admitted in the 
ICU ward. The mortality rate was 18 and 17 percent in 
hypo and normomagnesaemics respectively. In the 
present study, six patients died out of the total 
admitted patients to the intensive cardiac care unit, and 
among them three had hypomagnesaemia ranging 
from 0.8 to 1.6 mg/dl, two patients had serum 
magnesium levels between 1.7 to 1.8 mg/dl, and only 
one patient had magnesium level above 2.0 mg/dl. The 
overall mortality rate of ICCU patients after discharge 
was 6.5 %, when we look at individual patients 50% of 
these deceased patients had magnesium in the range of 
0.6 to 1.6 mg/dl, a clear condition of 
hypomagnesaemia whereas two deceased patients had 
magnesium at the lower strata of normal range (1.7 to 
Table 7. Incidence of hypo- and normo-magnesaemia among filtered and non-filtered water users across the 
groups of healthy, ICCU, and Non-ICCU subjects 
Group/ Subgroup Filtered water users   % (n) Non-filtered water users % (n) P value 
Healthy Subjects (n=185) 
Hypomagnesaemia 27% (16) 14% (17) 
0.040 
Normomagnesemia 73% (44) 86% (107) 
ICCU subjects (n=93) 
Hypomagnesaemia 90% (9) 36% (30) 
0.001 
Normomagnesemia 10% (1) 64% (53) 
Non-ICCU subjects (n=279) 
Hypomagnesaemia 60% (21) 32% (79) 
0.001 
Normomagnesemia 40% (14) 68% (164) 
1.8 mg/dl), as the cut off level for normomagnesaemia 
is 1.7 mg/dl.  
Only one of six diseased patients had above 2.0 mg/dl, 
considered to be having adequate magnesium levels. 
The results of the present study are in correlation with 
the findings reported by Limaye et al. [17] from 
Mumbai, the western part of India like our region. The 
results of both the studies from India are in a 
comparable range to the mortality rate reported from 
other parts of the world. Higher mortality rate observed 
in the case of hypomagnesaemia may be due to 
accompanied hypokalemia and cardiac arrhythmia or 
may be due to septic shock, which is a common cause 
of deaths in ICCU patients. One more point to be 
considered here is that in our study we have included 
subjects with only cardiovascular and diabetes, whereas 
various other studies included patients with other 
critical illnesses like infective conditions and cancers 
etc. in addition to cardiovascular diseases. 
Dabbagh et al. [30] concluded from his study that daily 
magnesium supplementation index higher than 1 gm/
day is associated with lower mortality rates in critically 
ill patients. This effect was not found to be independent 
and may be related to the severity of illness. If 
supplementation helps in the decrease of mortality rate 
among critically ill patients, it can further be explored 
by incorporating changes in lifestyle, and one such 
change can be the use of clean water by using 
appropriate water filters which maintain the original 
electrolytes present in the water to have better 
magnesium status.  
Further, we divided these study groups according to the 
type of water used for drinking and daily usage like 
cooking of food. These groups were divided into 
filtered water users and non-filtered water users. 
Filtered water users were utilizing various types of 
water filters to get clean water or to get soft water from 
hard ground water. The incidence of hypomagnesaemia 
was significantly high among filtered water users 
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compared to non-filtered water users as 27% v/s 14%, 
90% v/s 36%, and 60% v/s 32% in healthy, ICCU and 
non-ICCU subjects respectively (Table 7). We 
observed significantly low serum magnesium levels in 
filtered water users as compared to non-filtered water 
users among all the groups viz: healthy subjects, ICCU 
patients and NON-ICCU hospitalized patients (p-value 
<0.05) (Table 4, 5 & 6). But no significant difference 
in hypomagnesaemia was observed between ICCU and 
NON-ICCU hospitalized patients. These observations 
indicate that there is an association between serum 
magnesium status and nutritional quality of drinking 
water used by the study subjects in terms of 
magnesium content. 
Approximately 20 years ago, based on the available 
epidemiologic findings, the incidence of ischemic 
heart disease was highest among subjects from 
geographic regions of soft drinking water [31]. Of the 
minerals that are deficient in soft water, magnesium is 
the only element that is consistently lower in cardiac 
muscles of IHD victims  [21, 32]. Durlach [33] 
suggested that magnesium has a pre-eminent role 
amongst the numerous variables involved in the 
universe with the correlation between cardiovascular 
morbidity and mortality and the hardness of drinking 
water. Anderson [34,35] examined the incidence of 
acute and non-acute IHD in hard and soft water areas. 
Some workers [36] observed an association between 
water hardness and cardiovascular disease mortality, 
but these findings are questionable and need further 
research. Interesting observations were obtained when 
a study of finding water hardness and the levels of 
calcium and magnesium in these water samples from 
various sources and treatments was carried out. 60 to 
80% fall in total hardness and calcium, magnesium 
concentrations in water samples after filtration by 
various types of filters used by households to get 
purified water both in rural and urban areas of Surat 
was observed. Thus, rural ground water (unfiltered) 
and municipal piped water, which is prepared as per 
standards, becomes soft after the process of household 
filtration. In the case of bottled mineral water, the 
mineral content for calcium and magnesium was very 
negligible and almost nil, which is also used by the 
population for drinking and cooking purposes [19]. 
Body receives magnesium through food and water, but 
waterborne magnesium has great impact as a source of 
magnesium. First, the most significant factor is its 
bioavailability, almost 30% higher than food 
magnesium [37]. Water borne magnesium is directly 
available to the cells and tissues without any natural 
inhibitors for its absorption, unlike food magnesium. 
In our previous study, it was postulated that if 
sufficient supply of water borne magnesium is ensured 
that can fulfill the RDA for magnesium, less 
dependence will be on food borne magnesium. In such 
a scenario, even if less availability of food borne 
magnesium due to processing and cooking, water borne 
can take care of maintaining adequate body magnesium 
levels [19]. In a study by Leurs et al. [48] in the 
subgroup of men with a low dietary magnesium intake, 
a significant inverse association was found between tap 
water magnesium level and stroke mortality. This 
inverse association was not significant for IHD 
mortality. This observation supports our hypothesis of 
the role of waterborne magnesium in the status of 
hospitalized ICCU patients. Of course, large sample 
size is required to get a definitive conclusion regarding 
mortality and body magnesium status and status of 
waterborne and dietary magnesium   
CONCLUSION 
Forty two percentage prevalence of hypomagnesaemia 
was observed among ICCU patients. It supports the 
earlier findings that hypomagnesaemia in ICCU patients 
may be a significant comorbid factor, hence the 
necessity of supplementation of magnesium to maintain 
magnesium balance for better clinical outcomes in 
ICCU patients. The high mortality rate was observed in 
hypomagnesaemic patients compared to 
normomagnesaemic patients based on outcome of 
mortality findings, though our data was not very large to 
come to definitive conclusions. 
Significant hypomagnesaemia was observed among 
filtered water users in all the categories of subjects, 
strongly suggestive of the role of waterborne 
magnesium in maintaining magnesium status of the 
population. It implies the necessity of applying caution 
in selecting an appropriate filter for the collection of 
water for drinking and household purposes.  
The present study also suggests that it is necessary to 
make mandatory to include the analysis of serum 
magnesium in all the hospitalized patients and 
particularly in the patients admitted in critical care units 
and dialysis units etc.  
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